Literature DB >> 25215610

Evidence-based review of gastrointestinal bleeding in the chronic kidney disease patient.

Richard S Kalman1, Marcos C Pedrosa.   

Abstract

Patients with end-stage renal disease are more likely to suffer from gastrointestinal (GI) problems, including bleeding from upper and lower sources. Peptic ulcer disease is the most common cause of upper GI bleeding, and although there is some debate in the literature regarding whether the frequency of ulcer disease is higher in patients with kidney disease, it is well established that outcomes are worse in patients with compromised renal function. Angioectasias can be found throughout the GI tract and are another common cause of bleeding; management can be divided into localized endoscopic therapy and systemic hormonal treatment, or surgery for refractory cases. The most frequent causes of lower GI bleeding in this population, in addition to angioectasias, are diverticulosis, hemorrhoids, and ischemic colitis.
© 2014 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2014        PMID: 25215610     DOI: 10.1111/sdi.12301

Source DB:  PubMed          Journal:  Semin Dial        ISSN: 0894-0959            Impact factor:   3.455


  17 in total

1.  Clopidogrel Drug Interactions and Serious Bleeding: Generating Real-World Evidence via Automated High-Throughput Pharmacoepidemiologic Screening.

Authors:  Charles E Leonard; Meijia Zhou; Colleen M Brensinger; Warren B Bilker; Samantha E Soprano; Thanh Phuong Pham Nguyen; Young Hee Nam; Jordana B Cohen; Sean Hennessy
Journal:  Clin Pharmacol Ther       Date:  2019-07-04       Impact factor: 6.875

2.  Diagnostic evaluation and assessment of anemia in a patient with chronic kidney disease and gastrointestinal angioectasias undergoing hemodialysis.

Authors:  Karen Courville; Walter Bernal; Dimas Quiel; Maydelin Pecchio; Norman Bustamante; Iván Landires
Journal:  Clin Case Rep       Date:  2022-07-11

3.  Upper Gastrointestinal Bleeding in Patients with End Stage Renal Disease: Causes, Characteristics and Factors Associated with Need for Endoscopic Therapeutic Intervention.

Authors:  Syed Mudassir Laeeq; Abbas Ali Tasneem; Farina M Hanif; Nasir Hassan Luck; Rajesh Mandhwani; Rajesh Wadhva
Journal:  J Transl Int Med       Date:  2017-06-30

4.  Predictors of poor outcome in gastrointestinal bleeding in emergency department.

Authors:  Ender Kaya; Mehmet Ali Karaca; Deniz Aldemir; M Mahir Ozmen
Journal:  World J Gastroenterol       Date:  2016-04-28       Impact factor: 5.742

5.  Colonic diverticular disease in autosomal dominant polycystic kidney disease: is there really an association? A nationwide analysis.

Authors:  Rodrigo Duarte-Chavez; Jill Stoltzfus; Vikas Yellapu; Noel Martins; Sudip Nanda; Santo Longo; Berhanu Geme; Yecheskel Schneider
Journal:  Int J Colorectal Dis       Date:  2020-09-01       Impact factor: 2.571

6.  Inhibition of Gastric Acid Secretion by H2 Receptor Antagonists Associates a Definite Risk of Enteric Peritonitis and Infectious Mortality in Patients Treated with Peritoneal Dialysis.

Authors:  Miguel Pérez-Fontan; Daniela Machado Lopes; Alba García Enríquez; Beatriz López-Calviño; Andrés López-Muñiz; Teresa García Falcón; Ana Rodríguez-Carmona
Journal:  PLoS One       Date:  2016-02-12       Impact factor: 3.240

7.  Crystal-Associated Colitis with Ulceration Leading to Hematochezia and Abdominal Pain.

Authors:  Meeta Desai; Aaron Reiprich; Nancy Khov; Zhaohai Yang; Abraham Mathew; John Levenick
Journal:  Case Rep Gastroenterol       Date:  2016-06-27

8.  Prevalence of upper gastrointestinal bleeding risk factors among the general population and osteoarthritis patients.

Authors:  Sang Hyuck Kim; Jae Moon Yun; Chong Bum Chang; Heng Piao; Su Jong Yu; Dong Wook Shin
Journal:  World J Gastroenterol       Date:  2016-12-28       Impact factor: 5.742

9.  Solitary Polypoid Angiodysplastic Lesion Mimicking a Tumor in the Jejunum.

Authors:  Abhishek D Polavarapu; Mayurathan Kesavan; Vivek V Gumaste; Monika Wrzolek; Elias Purow
Journal:  ACG Case Rep J       Date:  2017-06-21

10.  Efficacy and safety of pasireotide-LAR for the treatment of refractory bleeding due to gastrointestinal angiodysplasias: results of the ANGIOPAS multicenter phase II noncomparative prospective double-blinded randomized study.

Authors:  Robert Benamouzig; Mourad Benallaoua; Jean-Christophe Saurin; Marouane Boubaya; Christophe Cellier; René Laugier; Magalie Vincent; Christian Boustière; Rodica Gincul; Elia Samaha; Philippe Grandval; Thomas Aparicio; Gheorghe Airinei; Bakhtiar Bejou; Cyriaque Bon; Jean-Jacques Raynaud; Vincent Levy; Denis Sautereau
Journal:  Therap Adv Gastroenterol       Date:  2018-02-16       Impact factor: 4.409

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.